
AMCP comments on Trump Administration demands for manufacturers to take action on Most-Favored-Nation pricing scheme
On November 20, HHS released a Final Rule that amends the discount safe harbor regulation to eliminate protections for price concessions offered by pharmaceutical manufacturers to plan sponsors and pharmacy benefit managers (PBMs) under contract with plan sponsors starting January 1, 2022.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.